KalVista pill reduces swelling symptoms caused by genetic disease, achieving goal of late-stage study February 23, 2024
KalVista Pharmaceuticals Reports Phase 3 Trial Meets All Endpoints for Sebetralstat as First Oral On-demand Therapy for Hereditary Angioedema February 23, 2024
Be Biopharma Expands Leadership Team as Company Transitions to Clinical Stage Organization January 5, 2024
Sitryx announces collaboration partner Lilly has commenced a Phase 1 study of SIT-011 for chronic autoimmune and inflammatory diseases January 4, 2024
